The FDA approved Pentax’s ED34-i10T, a duodenoscope with a disposable, single-use distal cap.
Allergan’s board of directors authorized the company to buy back $2 billion in stock, while also committing to increasing its quarterly dividends and reaffirming its decision to pay down $3.75 billion in debt by 2018.
The FDA approved Bracco Diagnostics’ Tagitol V oral suspension for adult patients undergoing virtual colonoscopy.
A study from England-based Oxford University further validated Medial EarlySign’s ColonFlag.
Landos Biopharma completed a series A financing round raising $10 million.
More articles on gastroenterology:
Landos Biopharma raises $10M in series A funding round — 3 insights
GI leader to know: Dr. Nicole Griglione of GI Associates
Stock market week-in-review for 5 large GI companies — Sept. 18-22
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
